IRIS
CERNARO, Valeria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.556
EU - Europa 3.905
AS - Asia 2.593
SA - Sud America 896
AF - Africa 73
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 6
Totale 12.042
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.449
RU - Federazione Russa 1.416
SG - Singapore 1.064
BR - Brasile 797
CN - Cina 773
IE - Irlanda 714
SE - Svezia 601
HK - Hong Kong 323
IT - Italia 292
DE - Germania 238
PL - Polonia 165
VN - Vietnam 133
GB - Regno Unito 121
FI - Finlandia 113
IN - India 100
FR - Francia 83
CA - Canada 53
MX - Messico 37
TR - Turchia 36
AR - Argentina 35
ZA - Sudafrica 28
BE - Belgio 25
BD - Bangladesh 24
EC - Ecuador 22
CZ - Repubblica Ceca 19
ES - Italia 19
NL - Olanda 19
AT - Austria 17
JP - Giappone 16
ID - Indonesia 15
UA - Ucraina 15
UZ - Uzbekistan 15
IQ - Iraq 13
PK - Pakistan 12
CO - Colombia 11
MA - Marocco 11
AE - Emirati Arabi Uniti 9
AU - Australia 9
KE - Kenya 9
PY - Paraguay 9
AZ - Azerbaigian 8
KG - Kirghizistan 8
CH - Svizzera 7
CI - Costa d'Avorio 7
PE - Perù 7
CL - Cile 6
EG - Egitto 6
VE - Venezuela 6
EU - Europa 5
JM - Giamaica 5
NO - Norvegia 5
TN - Tunisia 5
AL - Albania 4
BG - Bulgaria 4
IL - Israele 4
LT - Lituania 4
LV - Lettonia 4
NZ - Nuova Zelanda 4
PS - Palestinian Territory 4
AM - Armenia 3
BH - Bahrain 3
BY - Bielorussia 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
HN - Honduras 3
KR - Corea 3
LK - Sri Lanka 3
RO - Romania 3
SA - Arabia Saudita 3
TW - Taiwan 3
AO - Angola 2
BN - Brunei Darussalam 2
GE - Georgia 2
GR - Grecia 2
JO - Giordania 2
LB - Libano 2
MD - Moldavia 2
OM - Oman 2
PA - Panama 2
SN - Senegal 2
TJ - Tagikistan 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
GI - Gibilterra 1
GT - Guatemala 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
MK - Macedonia 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
PH - Filippine 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
RW - Ruanda 1
Totale 12.037
Salva come PNG Salva come JPEG
Città #
Moscow 723
Dublin 714
Dallas 689
Ashburn 648
Chandler 578
Singapore 519
Nyköping 336
Hong Kong 321
Beijing 307
Warsaw 153
New York 147
Los Angeles 135
The Dalles 126
Munich 112
Dearborn 111
Boardman 108
Princeton 105
Jacksonville 102
Medford 94
Ann Arbor 90
Messina 79
Des Moines 74
Cambridge 73
São Paulo 64
Jinan 56
Shenyang 50
Bremen 45
Ho Chi Minh City 45
Redondo Beach 45
Houston 44
Hyderabad 40
San Mateo 39
Buffalo 38
Tianjin 38
Turku 37
Pune 30
Frankfurt am Main 28
Hanoi 28
Wilmington 28
Lancaster 27
Catania 25
Montreal 25
Seattle 25
Brooklyn 24
Brussels 23
Nanjing 22
Rio de Janeiro 22
Johannesburg 20
Santa Clara 20
Belo Horizonte 19
Denver 19
Hebei 19
Stockholm 19
Orem 18
Ankara 16
Curitiba 16
Haikou 16
Poplar 16
Tokyo 16
Brasília 15
Brno 15
Hangzhou 15
Ningbo 15
Chicago 14
London 14
Mexico City 14
Phoenix 14
Düsseldorf 13
Jiaxing 12
Lentini 12
Nuremberg 12
San Francisco 12
Tashkent 12
Palermo 11
Taizhou 11
Toronto 11
Zhengzhou 11
Amsterdam 10
Campinas 10
Chennai 10
Dong Ket 10
Goiânia 10
Manchester 10
Porto Alegre 10
Portsmouth 10
Salvador 10
Wroclaw 10
Columbus 9
Helsinki 9
Jakarta 9
Nanchang 9
Baghdad 8
Baku 8
Bishkek 8
Charlotte 8
Fuzhou 8
Guayaquil 8
Haiphong 8
Nairobi 8
Norwalk 8
Totale 7.847
Salva come PNG Salva come JPEG
Nome #
[Long-term outcome of renal function in women with preeclampia and pregestational diabetes] 203
[Lupus Nephritis and Enteritis, a dual simultaneous involvement with Arteriolar Thrombosis] 190
[Periorbital purpura: a pathognomonic but late sign of AL amyloidosis] / Porpora periorbitaria: un segnale patognomonico ma tardivo di amiloidosi AL 190
Metformin-related lactic acidosis: is it a myth or an underestimated reality? 186
Mortalità e morbidità dei pazienti dializzati in Sicilia: studio epidemiologico analitico sul confronto tra metodiche convettive e diffusive 186
[Complement factor B mutation in atypical hemolytic uremic syndrome. Rare cause of rare disease] 179
[From hyponatremia to tolvaptan] 177
Auxine: thermodynamic properties, complexing ability and dosage in human serium 168
[Long-term outcome of renal function in women with preeclampia and pregestational diabetes] 164
[From oxygen to erythropoietin, as a protagonist of the skin-brain-kidney axis]. 162
ANTI-INFLAMMATORY ACTION OF DENOSUMAB IN VIVO AND IN VITRO 160
Sclerostin levels in uremic patients: a link between bone and vascular disease 156
AKI - EXPERIMENTAL MODELS 151
Role of Paricalcitol in Modulating the Immune Response in Patients with Renal Disease 151
Progress in pharmacotherapy for the treatment of hyperphosphatemia in renal failure 147
Delayed graft function and chronic allograft nephropathy: Diagnostic and prognostic role of neutrophil gelatinase-associated lipocalin 147
Auxin induces cell proliferation in an experimental model of mammalian renal tubular epithelial cells 147
A new therapy for kidney injury: regeneration. 133
Before and after preeclampsia: What biomarkers are there? 133
Down with the erythropoietin. Long live the erythropoietin! 132
Beneficial effects of oral pure caffeine on oxidative stress 131
Apelin, Plasmatic Osmolality and Hypotension in Dialyzed Patients. 130
Antioxidant agents for delaying diabetic kidney disease progression: A systematic review and meta-analysis 129
Marked improvement of thyroid function and autoimmunity by Aloe barbadensis miller juice in patients with subclinical hypothyroidism 128
Fibrosis, regeneration and cancer: what is the link? 127
Erythropoietin and the truths of science. 124
Kidney disease and psoriasis: novel evidences beyond old concepts 123
Nephro-oncology: a link in evolution 122
The Myth of Water and Salt: From Aquaretics to Tenapanor 122
From water to aquaretics: a legendary route. 121
Renoprotective effect of erythropoietin in zebrafish after administration of gentamicin: an immunohistochemical study for β-catenin and c-kit expression 121
Acetate-free biofiltration to remove fibroblast growth factor 23 in hemodialysis patients: a pilot study 120
Opposite actions of urotensin II and relaxin-2 on cellular expression of fibronectin in renal fibrosis: A preliminary experimental study 120
Gender differences in new hypoglycemic drug effects on renal outcomes: a systematic review 120
COMPARISON OF SEVELAMER, SEVELAMER CARBONATE AND LANTHANIUM CARBONATE IN VITRO AND IN VIVO 119
Vascular access for hemodialysis: current perspectives 119
Salt-water imbalance and fluid overload in hemodialysis patients: a pivotal role of corin 118
Relaxin: New Pathophysiological Aspects and Pharmacological Perspectives for an Old Protein. 117
L’ERITROPOIETINA HA AZIONE NEFROPROTETTIVA IN UN MODELLO SPERIMENTALE DI ZEBRAFISH (DANIO RERIO) DOPO SOMMINISTRAZIONE DI GENTAMICINA 117
Monoclonal antibodies for renal diseases: current concepts and ongoing treatments 117
The relationship between coping, emotion regulation, and quality of life of patients on dialysis 117
Kidney-lung connections in acute and chronic diseases: current perspectives 117
Semaphorin 3A serum levels are influenced by haemodialysis: what clinical significance? 116
Squilibri idrico-salini e sovraccarico di liquidi nei pazienti dializzati, il ruolo centrale di Corin 115
Lipid disorders in patients with renal failure: Role in cardiovascular events and progression of chronic kidney disease 115
L'AUXINA INDUCE PROLIFERAZIONE CELLULARE IN UN MODELLO SPERIMENTALE DI CELLULE EPITELIALI TUBULARI RENALI 114
Cross-sectional evaluation of kidney function in hospitalized patients: estimated GFR versus renal scintigraphy 114
Role of Vitamin D in Vascular Complications and Vascular Access Outcome in Patients with Chronic Kidney Disease 113
Negative Emotions in End-Stage Renal Disease: Are Anxiety Symptoms Related to Levels of Circulating Catecholamines? 113
Convective Dialysis Reduces Mortality Risk: Results From a Large Observational, Population-Based Analysis 113
ERYTHROPOIETIN EXERTS A RENOPROTECTIVE ACTION IN AN EXPERIMENTAL MODEL OF ZEBRAFISH (DANIO RERIO) AFTER ADMINISTRATION OF GENTAMICIN 111
Proteinuric effect of transcranial magnetic stimulation in healthy subjects and diabetic patients with stage 3-4 CKD 110
Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis 110
CIGARETTE SMOKE AND ENDOTHELIAL DYSFUNCTION: NGAL A NEW BIOMARKER 109
Stress-induced hashitoxicosis: Case report and relative HLA serotype and genotype 109
SCLEROSTIN CAN BE A NEW "KEY PLAYER" IN VASCULARCALCIFICATION IN CKD? 108
Kidney biopsy in type 2 diabetic patients: Critical reflections on present indications and diagnostic alternatives 108
Maternal and Fetal Outcomes of Pregnancy in Nephrotic Syndrome Due to Primary Glomerulonephritis 108
Xanthine oxidase inhibitors for improving renal function in chronic kidney disease patients: An updated systematic review and meta-analysis 108
Erithropoietin exerts a renoprotective action in an experimental model of zebrafish (Danio Rerio) after administration of gentamicin 106
An overview of experimental and early investigational therapies for the treatment of polycystic kidney disease 105
COMPARISON OF FORMULAS TO ESTIMATE THE GLOMERULAR FILTRATION RATE WITH THAT OF SCINTIGRAPHY EVALUATION OF KIDNEY FUNCTION IN HOSPITALIZED PATIENTS 104
Antiproteinuric effect of DPP-IV inhibitors in diabetic and non-diabetic kidney diseases 104
New options for the management of polycystic kidney disease 103
QUANTITATIVE ULTRASOUND OF BONE AND HANDGRIP STRENGTH ARE RELATED TO FRACTURE RISK IN HEMODIALYSIS PATIENTS 103
Regenerative medicine: does Erythropoietin have a role? 101
Indole-3-acetic acid correlates with monocyte-to-high-density lipoprotein (HDL) ratio (MHR) in chronic kidney disease patients 100
Renal biopsy: Still a landmark for the nephrologist 98
Correlation between Hyperkalemia and the Duration of Several Hospitalizations in Patients with Chronic Kidney Disease 97
Unexpected hypercalcemia in a diabetic patient with kidney disease 96
Complement Inhibition Therapy and Dialytic Strategies in Paroxysmal Nocturnal Hemoglobinuria: The Nephrologist's Opinion 96
NEW MARKERS OF VASCULAR AND CARDIAC DYSFUNCTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) 94
Role of Vitamin D Status in Diabetic Patients with Renal Disease 94
Erythropoiesis and chronic kidney disease–related anemia: From physiology to new therapeutic advancements 93
Novel avenues for treating diabetic nephropathy: new investigational drugs 91
RAS inhibition modulates kynurenine levels in a CKD population with and without type 2 diabetes mellitus 90
NGAL AND ANESTHETICS: PROTECTIVE ROLE OF SEVOFLURANE 89
FP042AUXIN INDUCES CELL PROLIFERATION IN AN EXPERIMENTAL MODEL OF MAMMALIAN RENAL TUBULAR EPITHELIAL CELLS 89
Higher serum sclerostin levels and insufficiency of vitamin D are strongly associated with vertebral fractures in hemodialysis patients: a case control study 86
NGAL is a precocious marker of therapeutic response. 85
Modifications in relaxin's serum levels during acetate-free biofiltration (AFB): only a new biomarker? 85
Does Erythropoietin Always Win? 84
Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials 83
Monocyte to HDL ratio: a novel marker of resistant hypertension in CKD patients 82
Protective role of vitamin d in renal tubulopathies 82
Maternal peripheral blood CD34+ cells for prediction of fetal kidney malformations: results from a case-control analysis 82
NGAL as an early biomarker of kidney disease in Joubert syndrome: three brothers compared. 76
Renal function is associated with changes in bone mineral density in postmenopausal osteoporotic women treated with Denosumab: data from a retrospective cohort study 75
Endothelial progenitor cells at the interface of chronic kidney disease: from biology to therapeutic advancement 75
New Insights on the Role of Vitamin D in the Progression of Renal Damage 74
Comparison between creatinine clearance and eGFRcyst-crea: a real-life experience 72
Differences in Efficacy between Antibacterial Lock Therapy and the Standard of Care for CVC-Related Infections: A Systematic Review and Meta-Analysis 72
Autoimmunity and Infection in Glomerular Disease 68
Regeneration and the Plant We have Inside 67
UROTENSIN AND RELAXIN: OPPOSITE ACTIONS AND POTENTIAL THERAPEUTIC APPLICATIONS IN RENAL FIBROSIS 66
Clinical evaluation of the safety, efficacy and tolerability of lanthanum carbonate in the management of hyperphosphatemia in patients with end-stage renal disease 66
The future of phosphate binders: a perspective on novel therapeutics 65
Immune Checkpoint Inhibitors and the Kidney: A Focus on Diagnosis and Management for Personalised Medicine 64
Commonly used immunosuppressive drugs for kidney diseases and pregnancy: focus on open questions 64
Phosphate binders for the treatment of chronic kidney disease: role of iron oxyhydroxide 64
Totale 11.325
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.328
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.328
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021141 0 0 0 0 0 19 17 9 18 47 14 17
2021/2022818 13 84 21 48 47 8 50 32 7 172 103 233
2022/20232.076 146 231 88 153 165 191 9 124 886 14 53 16
2023/2024613 37 54 27 42 53 196 18 27 5 59 11 84
2024/20252.582 47 19 50 157 69 107 102 485 608 210 281 447
2025/20264.765 526 536 755 641 779 1.528 0 0 0 0 0 0
Totale 12.309